Sign in
4

Changes in Ownership

Candel Therapeutics, Inc. Filed Acc 0000950170-24-137889

Director bought 1,250,000 shares at $6.00 ($7,500,000)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Manning Paul B Director 2024-12-16 Purchase +500,000 $6.00 $3,000,000 1,142,406 I
Manning Paul B Director 2024-12-16 Purchase +750,000 $6.00 $4,500,000 1,303,752 I
Open-market purchases · 1,250,000 sh · avg $6.00 · $7,500,000
Loading xslF345X05/ownership.xml…